Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer.

MLA

Stella, Stefania, et al. “Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer.” Cancer Genomics & Proteomics, vol. 19, no. 4, July 2022, pp. 464–76. EBSCOhost, https://doi.org/10.21873/cgp.20333.

APA

Stella, S., Vitale, S. R., Massimino, M., Motta, G., Longhitano, C., Lanzafame, K., Martorana, F., Fazzari, C., Vecchio, G. M., Tirrò, E., Inzerilli, N., Carciotto, R., Manzella, L., Caruso, M., & Vigneri, P. (2022). Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer. Cancer Genomics & Proteomics, 19(4), 464–476. https://doi.org/10.21873/cgp.20333

Chicago

Stella, Stefania, Silvia Rita Vitale, Michele Massimino, Gianmarco Motta, Claudio Longhitano, Katia Lanzafame, Federica Martorana, et al. 2022. “Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer.” Cancer Genomics & Proteomics 19 (4): 464–76. doi:10.21873/cgp.20333.